Dr. Everett Vokes, MD
Claim this profileThe University of Chicago Medical Center
Affiliated Hospitals
The University Of Chicago Medical Center
University Of Chicago Medicine Comprehensive Cancer Center
Clinical Trials Everett Vokes, MD is currently running
IPH5201 + Durvalumab + Chemotherapy
for Lung Cancer
In Cohort 1, the study was intended to assess safety and efficacy of neoadjuvant combination of IPH5201 and durvalumab in addition to standard chemotherapy and adjuvant combination of IPH5201 and durvalumab, in untreated patients with resectable, early-stage (stage II to IIIA) non-small cell lung cancer (NSCLC). Study Design was updated following the results of interim analysis # 2 (protocol amendment, adding cohort 2). Cohort 2 includes patients with resectable Stage II to IIIB NSCLC expressing PD-L1 ≥1%, receiving (only) neoadjuvant IPH5201+ durvalumab + chemotherapy
Recruiting
1 award
Phase 2
11 criteria
Nivolumab Safety
for Cancer
Main Objective of this study is to examine long-term safety of nivolumab monotherapy including combinations and other cancer therapies in various tumor types.
Recruiting
1 award
Phase 2
More about Everett Vokes, MD
Clinical Trial Related
7 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Everett Vokes, MD has experience with
- Nivolumab
- Carboplatin
- Paclitaxel
- Durvalumab
- IPH5201
- Standard Chemotherapy
Breakdown of trials Everett Vokes, MD has run
Tumor Exudate
Squamous Cell Carcinoma
Human Papillomavirus
Cervical Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Everett Vokes, MD specialize in?
Everett Vokes, MD focuses on Tumor Exudate and Cancer. In particular, much of their work with Tumor Exudate has involved treating patients, or patients who are undergoing treatment.
Is Everett Vokes, MD currently recruiting for clinical trials?
Yes, Everett Vokes, MD is currently recruiting for 2 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Everett Vokes, MD has studied deeply?
Yes, Everett Vokes, MD has studied treatments such as Nivolumab, Carboplatin, Paclitaxel.
What is the best way to schedule an appointment with Everett Vokes, MD?
Apply for one of the trials that Everett Vokes, MD is conducting.
What is the office address of Everett Vokes, MD?
The office of Everett Vokes, MD is located at: The University of Chicago Medical Center, Chicago, Illinois 60637 United States. This is the address for their practice at the The University of Chicago Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.